糖心原创

Physiology, Pharmacology and Neuroscience
 

Jacqueline Glenn

Technician, Faculty of Medicine & Health Sciences

Contact

Recent Publications

  • IY脷, D., GLENN, J.R., WHITE, A.E., JOHNSON, A., HEPTINSTALL, S. and FOX, S.C., 2012. Thrombosis and Haemostasis. 107(4), 797-799
  • GLENN JR, WHITE AE, IYU D and HEPTINSTALL S, 2012. Platelets. 23(5), 344-51
  • IYU, D., GLENN, J.R., WHITE, A.E., FOX, S.C. and HEPTINSTALL, S., 2011. Arteriosclerosis, Thrombosis and Vascular Biology. 31(2), 416-422
  • IY脷, D., J脺TTNER, M., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2011. Prostaglandins and Other Lipid Mediators. 94(1-2), 9-16
  • IY脷, D., GLENN, J.R., WHITE, A.E., JOHNSON, A., HEPTINSTALL, S. and FOX, S.C., 2012. Thrombosis and Haemostasis. 107(4), 797-799
  • GLENN JR, WHITE AE, IYU D and HEPTINSTALL S, 2012. Platelets. 23(5), 344-51
  • IYU, D., GLENN, J.R., WHITE, A.E., FOX, S.C. and HEPTINSTALL, S., 2011. Arteriosclerosis, Thrombosis and Vascular Biology. 31(2), 416-422
  • IY脷, D., J脺TTNER, M., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2011. Prostaglandins and Other Lipid Mediators. 94(1-2), 9-16
  • IY脷, D., GLENN, J.R., WHITE, A.E., FOX, S.C., GIEZEN, H. VAN, NYLANDER, S. and HEPTINSTALL, S., 2011. Thrombosis and Haemostasis. 105(1), 96-106
  • IY脷 D, GLENN JR, WHITE AE, FOX SC, DOVLATOVA N and HEPTINSTALL S, 2011. Platelets. 22(7), 504-15
  • IYU, D., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2010. Platelets. 21(5), 329-342
  • HEPTINSTALL S, IYU D, MANOLOPOULOS P, GLENN JR, WHITE AE, JOHNSON A, DOVLATOVA N, FOX SC, MAY JA, HERMANN D and MAGNUSSON O, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
  • MAY JA, FOX SC, GLENN JR, CRAXFORD S and HEPTINSTALL S, 2008. Platelet function reduces significantly during the morning. Platelets. 19(7), 556-8
  • MANOLOPOULOS, P., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N.L., TANG, S.-W., THOMAS, N.R., RALEVIC, V. and HEPTINSTALL, S., 2008. Platelets. 19(2), 134-145
  • GLENN JR, WHITE AE, JOHNSON AJ, FOX SC, MYERS B and HEPTINSTALL S, 2008. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Platelets. 19(1), 59-69
  • HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and AND MYERS, B., 2007. Leucocytes influence platelet aggregation more than you think Platelets. 18(1), 77-78
  • WHITE AE, GLENN JR, FOX SC, JOHNSON A, MYERS B and HEPTINSTALL S, 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100
  • HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R and JOHNSON, A.J. AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Thrombosis Research. 120(Supplement 2), S153-S154
  • HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R, JOHNSON, A.J and AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-356
  • HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54
  • HEPTINSTALL, STAN, GLENN, JACQUELINE R, JOHNSON, ANDREW, MYERS, BETHAN, WHITE, ANN E and ZHAO, LIAN, 2006. Arteriosclerosis, Thrombosis, and Vascular Biology. 26(2), e22-3
  • HEPTINSTALL, S., GLENN, J.R., JOHNSTON, A., WHITE, A. and MYERS, B., 2006. Leucocytes, leucocytosis and adenine nucleotide metabolism. Platelets. 17, 115
  • HEPTINSTALL, S., FOX, S.C., GLENN, J.R., JOHNSON, A., WHITE, A.E., DOLAN, G. and MYERS, B., 2006. Blood leucocytes are mobile modulators of adenine metabolism and play an important role in determining the effects of adenine nucleotides on platelet function. Purinergic Signalling. 2, 137
  • HEPTINSTALL, S., MANOLOPOULOS, M., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N., TANG, S-W., BAUER, N., HESSE, M., THOMAS, N.R. and RALEVIC, V., 2006. Acyl derivatives of coenzyme A inhibit ADP-induced platelet function via antagonism at P2Y1 and P2Y12 receptors. Purinergic Signalling. 2, 92-93
  • GLENN JR, WHITE AE, JOHNSON AJ, FOX SC, BEHAN MW, DOLAN G and HEPTINSTALL S, 2005. Platelets. 16(3-4), 159-70
  • HEPTINSTALL,S., TANG,S., MANOLOPOULOS,P., FOX,S., MAY,J., GLENN,J. and RALEVIC,V., 2005. Derivatives of coenzymes A inhibit platelet aggregation via efects at P2Y1 and P2Y12 receptors. In: 20th Congress of the International Society on Thrombosis & Haemostasis. OR334
  • GLENN, J.R., WHITE, A.E., JOHNSON, A., FOX, S. and BEHAN, M.W., 2005. Raised blood leukocyte counts markedly alter platelet aggregation extent induced by ADP and ATP via CD39. In: International Society of Thrombosis and Haemostasis, Sydney Aug 2005. PO942

Physiology, Pharmacology and Neuroscience

School of Life Sciences
糖心原创
Medical School
Queen's Medical Centre
Nottingham NG7 2UH